Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04748133
Other study ID # 6658
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 20, 2021
Est. completion date July 1, 2021

Study information

Verified date February 2021
Source Zagazig University
Contact Marwa Zakzouk, MD
Phone 01004178761
Email dr.marwa.zu@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Modern surgery management needs increasing operating room turnover and more ambulatory surgery. In order to come over this challenge, the recovery needs to be optimized. Enhancing recovery could be achieved by preventing postoperative pain and postoperative nausea and vomiting. Middle ear surgery is a common ambulatory surgery with increasing occurrence of postoperative nausea and vomiting.


Description:

Sample size: as percent of vomiting following acupuncture and following standard anesthesia is 0.13% and 29.2% respectively so sample size is 58 (29 in each group). Sample is calculated using open epi program with confidence level 95% and power 80%. Patients in Group C (control group) (n=29): will receive no treatment. While patients in Group A (Acupuncture group) (n=29): will receive needle acupuncture.


Recruitment information / eligibility

Status Recruiting
Enrollment 59
Est. completion date July 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 60 Years
Eligibility Inclusion Criteria: - Written informed consent from the patient. - Age: 21-60 years old. - Sex: both sex (males or females). - Physical status: ASA 1& II. - BMI = (20-30 kg/m2). - Type of operations: elective unilateral middle ear surgeries such as tempanoplasty, stapedectomy and mastedictomy. Exclusion Criteria: - Altered mental state - Patients with Drug abuse or alcohol. - Patients with on antipsychotic drugs, regular antiemetic therapy or receiving antiemetic 24 hour before surgery. - Patients with pre-treatment with acupuncture or trigger point injection. - Pregnancy.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
acupuncture needles
Site of acupuncture points: Du 26: At junction of the upper and middle third of philtrum. Ren 17: On the midline level with the 4th intercostal space midway between the nipples. LI4 (Large Intestine 4): On the dorsum of the hand, between the 1st and 2nd metacarpal bones HT7 (Heart 7): On the ulnar end of the transverse crease of the wrist, in the small depression between the pisiform and ulna bones LV3 (Liver 3): On dorsum of the foot in a depression distal to the junction of the 1st and 2nd metatarsal bones. ST36 (Stomach 36): Antero-lateral leg, 1 middle-finger breadth next to the anterior crest of tibia, 3 cun under the depression lateral to the patellar ligament. PC6 (Pericardium 6): Palmar aspect of the forearm, between the tendons, 2 cun away from the transverse crease of the wrist
Other:
placebo
no treatment

Locations

Country Name City State
Egypt Zagazig University Zagazig

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of postoperative nausea and vomiting Postoperative nausea and vomiting impact scale score . Questions Answers score Did you have vomiting or dry retching? No 0 Once 1 Twice 2 Three or more times 3
Have you experienced a feeling of nausea? If yes, has it interfered with your daily activities? Not at all 0 Sometimes 1 Often/most of the times 2 All the time 3
Summation of numerical answer to question 1 plus 2 equal the PONV impact scale. PONV Impact Scale Score of =5 represents clinically important PONV
up to 24 hours postoperative
Secondary extubation time time from discontinuation of isoflurane to extubation up to 10 minutes postoperative
Secondary recovery time time from discontinuation of isoflurane to first response to verbal command up to 30 minutes postoperative
Secondary The time of discharge The time from arrival to PACU to discharge to the ward) according to Modified Aldert score Modified Aldert score . Assessment item Condition Grade Activity, able to move, voluntarily or on command 4 extremities 2 2 extremities 1 No 0
Breathing Able to breathe deeply & cough freely 2 Dyspnea, shallow or limited breathing 1 Apnea 0 Consciousness Fully awake 2 Arousable on calling 1 Unresponsive 0
Circulation (blood pressure) ±20% of pre-anesthesia level 2
20% to 49% of pre-anesthesia level 1
50% of pre-anesthesia level 0 SPO2 Maintain SPO2 >92% in ambient air 2 Maintain SPO2 >90% with O2 1 Maintain SPO2 <90% with O2 0
Patient having a score of 9 or higher is discharged
up to 30 minutes postoperative
Secondary The total number of rescue antiemetic (metoclopramide) Any patient will receive 10 mg intravenous metoclopramide immediately if there is nausea and vomiting in the first 24 hour postoperative
Secondary Postoperative Pain Visual Analogue Scale (VAS) . A commonly used scale is a 10-cm line labeled with "worst pain imaginable" on the right border and "no pain" on the left border. The patient is instructed to make a mark along the line to represent the intensity of pain currently being experienced. IV paracetamol 1 gm every 6hs as a protocol for pain management and IV pethidine 30 mg as rescue analgesic will be given if VAS = 4. Total doses and number of analgesics will be recorded up to 30 minutes, 2 hours and 4 hours postoperative
Secondary number of participant with side effects of acupuncture bleeding, soreness, or bruising at the site of needle insertion up to 24 hours postoperative
See also
  Status Clinical Trial Phase
Completed NCT04653818 - HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial Phase 4
Not yet recruiting NCT06371677 - Polish Nationwide Register of Hospitalized Patients in Cardiac Intensive Care Units
Recruiting NCT06152198 - Internal Fixation vs Hip Arthroplasty in Older Adults With an Undisplaced Femoral Neck Fracture: A Substudy of the Hipsther Trial N/A
Completed NCT05193877 - Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022 N/A
Recruiting NCT06373471 - Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment N/A
Recruiting NCT05371938 - Volar Locking Plate Versus External Fixation for Distal Radius Fracture - a Longterm Follow up N/A